Alyeska Investment Group, L.P. Infla Rx N.V. Transaction History
Alyeska Investment Group, L.P.
- $23.4 Billion
- Q1 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Infla Rx N.V. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 13,538 shares of IFRX stock, worth $11,507. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,538Holding current value
$11,507% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding IFRX
# of Institutions
36Shares Held
18.2MCall Options Held
33.6KPut Options Held
2.2K-
Suvretta Capital Management, LLC New York, NY6.48MShares$5.51 Million0.29% of portfolio
-
683 Capital Management, LLC New York, NY2.63MShares$2.23 Million0.22% of portfolio
-
Eversept Partners, LP New York, NY1.68MShares$1.42 Million0.19% of portfolio
-
Morgan Stanley New York, NY1.26MShares$1.07 Million0.0% of portfolio
-
Silverarc Capital Management, LLC1.16MShares$987,3310.29% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $37.6M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...